Login / Signup
Safety and benefit of incretin-based therapies in patients with type 2 diabetes: learnings and reflections.
Ali Abbas Rizvi
Ales Linhart
Michal Vrablik
Evangelos Liberopoulos
Manfredi Rizzo
Published in:
Expert opinion on drug safety (2022)
Keyphrases
</>